Literature DB >> 18428631

Overview on rodent models of Alzheimer's disease.

Jean-Cosme Dodart1, Patrick May.   

Abstract

In Alzheimer's disease (AD), characteristic lesions develop in brain regions that subserve cognitive functions, ultimately leading to dementia. There are now several lesioned or transgenic small-animal models of the disease that model select aspects of cognitive deficits and/or recapitulate many, but not all, of the characteristic pathologic lesions observed in AD. This overview describes the most common approaches used to model AD in rodents, highlights their utility, and discusses some of their deficiencies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 18428631     DOI: 10.1002/0471142301.ns0922s33

Source DB:  PubMed          Journal:  Curr Protoc Neurosci        ISSN: 1934-8576


  12 in total

1.  Knock-down of protein L-isoaspartyl O-methyltransferase increases β-amyloid production by decreasing ADAM10 and ADAM17 levels.

Authors:  Narkhyun Bae; Se Eun Byeon; Jihyuk Song; Sang-Jin Lee; Moosik Kwon; Inhee Mook-Jung; Jae Youl Cho; Sungyoul Hong
Journal:  Acta Pharmacol Sin       Date:  2011-03       Impact factor: 6.150

Review 2.  Neurovascular function in Alzheimer's disease patients and experimental models.

Authors:  Nektaria Nicolakakis; Edith Hamel
Journal:  J Cereb Blood Flow Metab       Date:  2011-04-06       Impact factor: 6.200

Review 3.  Transgenic animal models of neurodegeneration based on human genetic studies.

Authors:  Brandon K Harvey; Christopher T Richie; Barry J Hoffer; Mikko Airavaara
Journal:  J Neural Transm (Vienna)       Date:  2010-10-08       Impact factor: 3.575

Review 4.  Cross currents in protein misfolding disorders: interactions and therapy.

Authors:  Rodrigo Morales; Kristi M Green; Claudio Soto
Journal:  CNS Neurol Disord Drug Targets       Date:  2009-11       Impact factor: 4.388

5.  PIB binding in aged primate brain: enrichment of high-affinity sites in humans with Alzheimer's disease.

Authors:  Rebecca F Rosen; Lary C Walker; Harry Levine
Journal:  Neurobiol Aging       Date:  2009-03-28       Impact factor: 4.673

6.  Intranasal delivery of human beta-amyloid peptide in rats: effective brain targeting.

Authors:  Eszter Sipos; Anita Kurunczi; András Fehér; Zsuzsa Penke; Lívia Fülöp; Agnes Kasza; János Horváth; Sándor Horvát; Szilvia Veszelka; Gábor Balogh; Levente Kürti; István Eros; Piroska Szabó-Révész; Arpád Párducz; Botond Penke; Mária A Deli
Journal:  Cell Mol Neurobiol       Date:  2009-10-06       Impact factor: 5.046

7.  Post-mortem analysis of neuroinflammatory changes in human Alzheimer's disease.

Authors:  Diego Gomez-Nicola; Delphine Boche
Journal:  Alzheimers Res Ther       Date:  2015-04-22       Impact factor: 6.982

8.  Studies for Improving a Rat Model of Alzheimer's Disease: Icv Administration of Well-Characterized β-Amyloid 1-42 Oligomers Induce Dysfunction in Spatial Memory.

Authors:  Ágnes Kasza; Botond Penke; Zsuzsanna Frank; Zsolt Bozsó; Viktor Szegedi; Ákos Hunya; Klaudia Németh; Gábor Kozma; Lívia Fülöp
Journal:  Molecules       Date:  2017-11-18       Impact factor: 4.411

Review 9.  Mitochondrial dynamics--fusion, fission, movement, and mitophagy--in neurodegenerative diseases.

Authors:  Hsiuchen Chen; David C Chan
Journal:  Hum Mol Genet       Date:  2009-10-15       Impact factor: 6.150

Review 10.  The Benefits of Exercise on Structural and Functional Plasticity in the Rodent Hippocampus of Different Disease Models.

Authors:  Anna R Patten; Suk Yu Yau; Christine J Fontaine; Alicia Meconi; Ryan C Wortman; Brian R Christie
Journal:  Brain Plast       Date:  2015-10-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.